NCT00478621View on ClinicalTrials.gov

Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

PHASE1CompletedINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

May 25, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

October 13, 2008

Conditions
Infections, Papillomavirus
Interventions
BIOLOGICAL

GSK Biologicals' HPV vaccine (GSK1674330A)

Intramuscular administration, 5 different formulations

BIOLOGICAL

Cervarix TM

Intramuscular administration

Trial Locations (3)

1070

GSK Investigational Site, Brussels

2610

GSK Investigational Site, Wilrijk

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY